These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Broze GJ Semin Hematol; 1992 Jul; 29(3):159-69. PubMed ID: 1641662 [No Abstract] [Full Text] [Related]
7. Synergism between full length TFPI and heparin: evidence for TFPI as an important factor for the antithrombotic activity of heparin. Valentin S; Ostergaard P; Kristensen H; Nordfang O Blood Coagul Fibrinolysis; 1992 Apr; 3(2):221-2. PubMed ID: 1318759 [No Abstract] [Full Text] [Related]
8. Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulation. Lindahl AK; Abildgaard U; Larsen ML; Aamodt LM; Nordfang O; Beck TC Thromb Res Suppl; 1991; 14():39-48. PubMed ID: 1658969 [TBL] [Abstract][Full Text] [Related]
9. The role of the C-terminal domain in the inhibitory functions of tissue factor pathway inhibitor. Ettelaie C; Adam JM; James NJ; Oke AO; Harrison JA; Bunce TD; Bruckdorfer KR FEBS Lett; 1999 Dec; 463(3):341-4. PubMed ID: 10606750 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184 [TBL] [Abstract][Full Text] [Related]